Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration

Figure 1

The PTCD1 expression level and survival analysis in BLCA. (a) The PTCD1 expressions of patients with BLCA according to different clinical characteristics including age (a), gender (b), stage (c), and grade (d). The PTCD1 expression (e), OS (f), PFS (g), and DFS (h) of stages I-II versus stages III-IV in the TCGA-BLCA dataset. The K-M curve between low-PTCD1 group and high-PTCD1 group in the TCGA database (i) and AUC curve related to OS (j). The survival curve based on the median expression of PTCD1 as the threshold in ENCORI database (k). Protein expression of PTCD1 in normal bladder tissue (l), low-grade (m) and high-grade (n) bladder cancer. ; ; and .

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)